I just read the announcements again and I don't think so.
We are most pleased to advise that our new company is presently finalising a significant and material partnership agreement regarding our medical
cannabis formulations and hemp food consumables which will significantly move forward our production schedule and capacity in 2019, focusing on
generating substantial short term revenues for our Company. We will be updating the market with further details on this major development in the
coming days.
"material partnership agreement regarding our medical cannabis formulations and hemp food consumables which will significantly move forward our production schedule and capacity in 2019 "
Bonify and Pharmocan are only Medical Marijuana and have nothing to do with Hemp. The announcement clearly says that this is a single partnership and affects both parts of CGB which is why I am leaning towards a big investors
CGB Price at posting:
3.7¢ Sentiment: Buy Disclosure: Held